trending Market Intelligence /marketintelligence/en/news-insights/trending/d363Pn38aXEIIIZ3NDQRaA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Tonix Pharmaceuticals plans common stock offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Tonix Pharmaceuticals plans common stock offering

Tonix Pharmaceuticals Holding Corp. plans to offer and issue common stock in an underwritten public offering.

The company expects to use the net proceeds to support the continued development of TNX-102 SL for the treatment of post-traumatic stress disorder, including the HONOR study in military-related PTSD, to further develop other pipeline programs, for working capital and other general corporate purposes and possibly acquisitions of other companies, products or technologies.

Aegis Capital Corp. is acting as the sole book-running manager in the offering.